Contact Person

SeSaM-Biotech
Mr.
David
Schönauer
CEO
+49 241 938 569 79

News

Lessons from diversity of directed evolution experiments by an analysis of 3,000 mutations.
14 July 2014
Zhao J, Kardashliev T, Joelle
Biotechnol Bioeng 2014
Diversity generation by random mutagenesis is often the first key step in directed evolution...
read more >>
Bacillus gibsonii alkaline protease
1 November 2012
Martinez R, Jakob F, Tu R, Sie
Biotechnol Bioeng. 2013 Mar
Bacillus gibsonii Alkaline Protease (BgAP) is a recently reported subtilisin protease exhibiting...
read more >>
Review: To get what we aim for - progress in diversity generation methods
5 June 2013
Ruff AJ, Dennig A, Schwaneberg
FEBS J., 280 (2013), 2961-2978
Protein re-engineering by directed evolution has become a standard approach for tailoring enzymes...
read more >>
Reengineered glucose oxidase for amperometric glucose determination in diabetes analytics
20 June 2013
Arango Gutierrez E, Mundhada H
Biosensors and Bioelectronics
Glucose oxidase is an oxidoreductase exhibiting a high β-d-glucose specificity and high stability...
read more >>

-

Home

Welcome to SeSaM-Biotech

SeSaM-Biotech provides companies and institutes with novel enzymes for research or biocatalysis in industrial or medical processes.

Watch a short introduction of SeSaM-Biotech given by our CEO, David Schönauer.

 

Our Technology

Our platform technology Sequence Saturation Mutagenesis (SeSaM) is an innovative, unmatched and patented method for generating unbiased diversity of proteins to discover new enzyme functionalities or improve given enzyme properties.

 

Our Products

Our protein engineering services include mutant gene libraries and enzyme evolution projects to obtain improved properties for research, medicine and industrial production. Additionally, we offer individual compounds for own successful directed evolution experiments.

Syndicate content